Chronic cannabis use reduced inflammatory markers CCL2 and IL-17 in both MS patients and healthy controls, while anandamide levels were elevated in MS patients regardless of cannabis use.
Read this if you have MS and use cannabis, and want to understand its effects on your immune system.
Cannabis use reduced IL-17, a key inflammatory marker in MS, in both patients and controls
What the researchers found
Monocyte migration (a measure of immune cell movement) was similarly inhibited by phytocannabinoids in samples from both MS patients and healthy controls, suggesting cannabis affects this immune parameter equally regardless of MS status.
Plasma levels of two inflammatory markers, CCL2 and IL-17, were reduced in chronic cannabis users compared to non-users across both groups. Since IL-17 is particularly important in MS pathology, this reduction could have therapeutic implications.
Anandamide (AEA) levels were significantly elevated in MS patients compared to controls, regardless of cannabis use. No significant differences were found in other endocannabinoids or signaling lipids. This elevation of anandamide may represent a compensatory response to the inflammatory disease process.
Why it matters
MS is an autoimmune disease where the immune system attacks the nervous system. If cannabis affects immune parameters similarly in MS patients and healthy people, this simplifies the interpretation of cannabis effects in MS. The reduction in IL-17, a key driver of MS pathology, is particularly noteworthy.
The numbers in context
CCL2 and IL-17 reduced in cannabis users in both groups. AEA elevated in MS patients vs. controls regardless of cannabis use. Monocyte migration similarly inhibited by phytocannabinoids in both groups.
How the study worked
Subjects with MS and healthy controls were enrolled and matched for age and BMI. Each provided a single blood draw. Researchers measured monocyte migration, plasma endocannabinoid levels, and cytokine levels. Cannabis use status was self-reported. Monocytes were tested for response to a set ratio of phytocannabinoids in vitro.
What this study cannot tell us
This was a cross-sectional study with a single blood draw, so it cannot assess whether the immune changes are clinically meaningful or sustained. The sample sizes were small. Cannabis use was self-reported and not standardized. The study measured a limited set of immune parameters and cannot characterize the full immunological impact.
How to read the evidence
This is a small cross-sectional study with a single measurement point. It provides preliminary immunological data.
When this study was published
Published in 2014. Research on cannabis and MS immunology has continued with interest in disease-modifying potential.
The bigger picture
Many MS patients use cannabis for symptom relief, but whether this use also modulates their underlying disease process through immune effects has been unclear. This study suggests cannabis has consistent immunomodulatory effects regardless of MS status, potentially offering disease-modifying benefits alongside symptom relief.
Questions still open
- Does the reduction in IL-17 from cannabis use translate to clinical benefit in MS? Is the elevated anandamide in MS patients protective or pathological? Would a controlled trial of cannabis in MS show measurable changes in disease progression through immune modulation?
Common questions
Why is IL-17 important in MS?
What does elevated anandamide in MS patients mean?
Read the original research
Cannabis use by individuals with multiple sclerosis: effects on specific immune parameters.
Inflammopharmacology, 22(5), 295-303
Citation
Sexton, Michelle; Cudaback, Eiron; Abdullah, Rehab A; Finnell, John; Mischley, Laurie K; Rozga, Mary; Lichtman, Aron H; Stella, Nephi. (2014). Cannabis use by individuals with multiple sclerosis: effects on specific immune parameters.. Inflammopharmacology, 22(5), 295-303. https://doi.org/10.1007/s10787-014-0214-z
Explore the wider topic
- CBD Oil Quality Guide: How to Avoid Snake Oil
- Anxiety After Quitting Weed: When to Consider Medication
- Cannabis for Chemotherapy Nausea: What the Evidence Actually Shows
- Cannabis for Chronic Pain: What the Research Actually Supports
- Cannabis and Epilepsy: The Epidiolex Story and What It Means
- Does CBD Actually Work for Anxiety? What the Evidence Shows
- Does CBD Help with Weed Withdrawal? What Studies Show
- CBD vs THC: The Differences That Actually Matter
- The Proven Medical Benefits of Cannabis: What Research Supports
- Quitting Weed Before Surgery
- Weed and Medications: What Changes When You Quit
- Quitting Weed During Pregnancy: What You Need to Know
- Quitting Weed While Pregnant: What You Need to Know
- Cannabis and Older Adults: Risks Seniors Should Know
- Cannabis and Breastfeeding: THC in Breast Milk